Amino acid profile and aromatic amino acid concentration in total parenteral nutrition: effect on growth, protein metabolism and aromatic amino acid metabolism in the neonatal piglet.
1. The protein and amino acid utilization of two commercially available amino acid solutions, one egg-patterned (Vamin), the other human-milk-patterned (Vaminolact), were studied in piglets receiving total parenteral nutrition. It was hypothesized that Vaminolact was deficient in total aromatic amino acids, so a third group received a human-milk-patterned amino acid solution with added phenylalanine. 2. The piglets were on total parenteral nutrition for 8 days from day 2 or 3 of life. They all received a total energy intake of 1040 kJ day-1 kg-1 with macronutrient intakes of 14.6 g of amino acid, 27.4 g of glucose and 9.4 g of fat day-1 kg-1. 3. Nitrogen balances were performed on days 3-8 of total parenteral nutrition. On day 8 a primed constant infusion of (1-14C]-phenylalanine was given to measure phenylalanine flux and fractional conversion to tyrosine. Transamination catabolites of phenylalanine and tyrosine were measured in urine on day 7. 4. The piglets receiving Vaminolact gained significantly less weight (0.86 kg compared with 1.18 kg for Vamin and 1.20 kg for phenylalanine-supplemented Vaminolact; P < 0.02) and nitrogen (1435 mg day-1 kg-1 compared with 1601 mg and 1836 mg day-1 kg-1 for the other groups; P < 0.0001). 5. The piglets receiving Vamin had high plasma phenylalanine levels (2234 mumol/l compared with 156 mumol/l for Vaminolact and 399 mumol for phenylalanine-supplemented vaminolact; P < 0.0001). Those receiving Vamin also had an elevated excretion of phenylalanine transamination metabolites and low plasma lysine levels. Phenylalanine flux was highest in the Vamin group, intermediate in the phenylalanine-supplemented Vaminolact group and lowest in the Vaminolact group. 6. We conclude that Vaminolact is limiting in aromatic amino acids and that the addition of phenylalanine to the level in Vamin significantly improves growth and nitrogen retention; however, increasing the phenylalanine content of total parenteral nutrition is not the most metabolically suitable way to provide aromatic amino acids in neonatal total parenteral nutrition.
Wykes
L J
LJ
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
House
J D
JD
Ball
R O
RO
Pencharz
P B
PB
D000596:Amino Acids / Q000008:administration & dosage*; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development / Q000378:metabolism*; D005526:Food, Formulated; D008239:Lysine / Q000097:blood; D009584:Nitrogen / Q000378:metabolism; D010289:Parenteral Nutrition, Total; D010649:Phenylalanine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D013552:Swine / Q000254:growth & development / Q000378:metabolism*; D014443:Tyrosine / Q000378:metabolism
D000596:Amino Acids; D014443:Tyrosine; D010649:Phenylalanine; D008239:Lysine; D009584:Nitrogen